BUY Dr. Reddy's Laboratories — CLSA, 10 Jul 2026

byClsaHorizon: NA (inferred 1 year)10 Jul 2026via Zee Business (Live)

Entry₹1,244.9Inferred

Target₹1,570

Stop lossNot given

CMP₹1,1511h ago

Active-7.54%+36.40%upside left 10 mo left

Follow Clsa for new calls(100% target hit, 13 closed calls)Get alerts Watch DRREDDY for new buy/sell callsGet alerts See 15 other Long-term calls on DRREDDY See 77 other Long-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 8 Sept, 6:01 pm IST

6 supporting7 neutral7 opposing

Supports the BUY call (6)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·11 Aug · 4w ago

4 other SEBI-registered advisors have active long-term BUY calls on this stock

Advisor consensus · same horizon·23 Jul · 2mo ago

Neutral / worth noting (7)

USFDA Closes Dr Reddy's UK API Plant Inspection With VAI Classification

NewsGoogle News·19 Aug · 3w ago

FDA closes Dr. Reddy’s (NYSE: RDY) UK plant inspection

NewsGoogle News·17 Aug · 3w ago

Weighs against the BUY call (7)

Long-term trend bearish — 200-day average falling over the past quarter

Technicals · trend·7 Sept · yesterday

FDA flags four issues at Dr. Reddy’s (NYSE: RDY) Hyderabad plant after August inspection

NewsGoogle News·17 Aug · 3w ago

6 other SEBI-registered advisors have active long-term SELL calls on this stock

Advisor consensus · same horizon·23 Jul · 2mo ago

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

BUY Dr. Reddy's Laboratories Limited — Clsa

AI Assessment